Not sure who signed with whom first, on a quick look online, looks like EU signed in June and UK later in July.
Regardless, If AZ signed up for 3bn and said were gonna supply in 80m by Q1 and only supply 30m then it’s a big drop and depends on how contract is worded sounds a breach.
However, I believe EU has so far only approved Moderna so sounds like they are being a bit cuntish still.
I was under the impression that 100m was to be produced in Wrexham anyway so again not sure about specifics about what they could block.
Yeah those made in the UK I believe are for the UK and maybe Europe once the UK order has been fulfilled. I would be very surprised if there was any specific wording, e.g. Q1, since no-one knew when the vaccine would be developed, fully tested and approved and ready for mass production, it could just have easily been next Autumn for example.
Guardian :
AstraZeneca warned the European commission on Friday that there would be a significant shortfall in the promised 100m vaccine doses this quarter, of
up to 60%. It says this is due to a technical issue: not enough vaccine is being produced by the main plant making the supplies destined for Europe, which is in Belgium.
Making vaccines is not like building houses, where you can add a few more bricks to a wall if it’s too short, they say. This is a biological process and it’s not possible to be certain how much vaccine is going to be made once production is under way. The yield varies.
In this case, there appears to have been a low yield from the cells dividing in the bioreactors in the Belgium plant. The same could happen in any of the other factories around the world making the Oxford/AstraZeneca vaccine, including the UK.
AstraZeneca’s chief executive, Pascal Soriot, spoke to EU president Ursula von der Leyen about this, telling her they would have to cut their supply of vaccines to Europe.
That went down badly in Europe, where there are already tensions over the low numbers immunised with the two jabs licensed so far – from Pfizer/BioNTech and Moderna. The UK is thought to have immunised 10% of its residents, and the EU just 2%. The EU’s health commissioner, Stella Kyriakides, said AstraZeneca must live up to its contractual obligations.
Will AstraZeneca dispatch extra doses to Europe from its vaccine production sites in the UK?
This looks unlikely or very difficult. AstraZeneca has committed to delivering 2m doses a week to the UK as part of its order for 100m doses in total. That is pushing capacity fairly hard and depends on no unforeseen issues arising, such as poor yield as in Belgium or other issues such as batch quality.
What can the European commission do?
There are tacit threats of vaccine wars.
The commission could take measures to block the Pfizer/BioNTech vaccine – which is made in Europe –
from being dispatched to the UK. Kyriakides said Brussels would now insist on being notified of any exports of vaccines from EU sites.